|
NDUFA11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.259500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.205700E-02 |
| Normal-vs-Stage2 |
8.468800E-01 |
| Normal-vs-Stage3 |
4.01020000000418E-05 |
| Normal-vs-Stage4 |
1.602120E-02 |
| Stage1-vs-Stage2 |
2.964000E-01 |
| Stage1-vs-Stage3 |
2.432400E-01 |
| Stage1-vs-Stage4 |
8.611400E-01 |
| Stage2-vs-Stage3 |
1.439020E-01 |
| Stage2-vs-Stage4 |
3.184600E-01 |
| Stage3-vs-Stage4 |
1.082820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.779500E-03 |
| Normal-vs-AfricanAmerican |
7.644600E-01 |
| Normal-vs-Asian |
2.110600E-01 |
| Caucasian-vs-AfricanAmerican |
4.690200E-02 |
| Caucasian-vs-Asian |
9.671800E-01 |
| AfricanAmerican-vs-Asian |
3.654200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.234200E-02 |
| Normal-vs-Female |
1.415120E-03 |
| Male-vs-Female |
6.975600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.715910E-02 |
| Normal-vs-Age(41-60Yrs) |
1.361850E-03 |
| Normal-vs-Age(61-80Yrs) |
3.249500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.069200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.280600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.594200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.536800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.037200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.678800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.055400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.039600E-02 |
| Normal-vs-Grade 2 |
8.058400E-02 |
| Normal-vs-Grade 3 |
3.004700E-03 |
| Normal-vs-Grade 4 |
3.936300E-03 |
| Grade 1-vs-Grade 2 |
3.461400E-01 |
| Grade 1-vs-Grade 3 |
4.184000E-01 |
| Grade 1-vs-Grade 4 |
5.717800E-01 |
| Grade 2-vs-Grade 3 |
7.899600E-01 |
| Grade 2-vs-Grade 4 |
5.936200E-01 |
| Grade 3-vs-Grade 4 |
6.518200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.63059999997084E-06 |
| Normal-vs-ccB subtype |
5.93099999999236E-05 |
| ccA subtype-vs-ccB subtype |
8.638400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.444000E-02 |
| Normal-vs-N1 |
1.462160E-01 |
| N0-vs-N1 |
8.580000E-01 |
|
|
